Eli Lilly’s top dealmaker says don’t be surprised to see more M&A that pushes Lilly into new areas
RSS SUMMARY · AGGREGATED FROM CNBC
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Meta is trying to sell AI agents to businesses in latest effort to diversify away from ads
CNBC·1h ago·3 min read
Business
Morgan Stanley will soon open its trillion-dollar wealth management funnel to AI agents
CNBC·1h ago·3 min read
US
Europe unveils tech sovereignty package amid growing concerns over reliance on U.S. tech
CNBC·2h ago·3 min read
Business
Private payrolls grew by 122,000 in May, stronger than expected, ADP reports
CNBC·2h ago·3 min read
Related
On this beat
Business
Wells Fargo reveals unexpected best days for stock market gains
THE STREET·1h ago·3 min read
Business
This Airline Was Just Named the Best in the U.S. for the 8th Year in Row—Here’s Why
INC·1h ago·3 min read
Business
We made Ina Garten’s easy 5-ingredient pasta. It was perfect for a summer weeknight meal.
BI·1h ago·3 min read
Business
Best Business Debt Consolidation Loans in June 2026
TWSJ·1h ago·3 min read